What is MDITI™?
Medical-Digital Infrared Thermographic Imaging™ is currently the only system capable of detecting developing breast cancer. Used extensively in human medicine in the U.S.A., Europe and Asia for the past 20 years, MDITI™ by HealthQuest® offers REAL early detection of breast cancer, up to 10 years BEFORE it becomes breast cancer. Finding out that early allows more time to apply truly preventive measures and adapt meaningful lifestyle, relational, dietary and nutritional changes.
Is it painful? How safe is it?
Unlike current breast cancer detecting systems, MDITI™ by HealthQuest® is really safe and PAIN-FREE since it does NOT use RADIATION, CHEMICAL or NEEDLES. There is totally NO contact, NO squeezing, NO pressure and is NON-invasive. It is also safe for pregnant women.
How accurate and accepted is it?
MDITI™'s 83% accuracy is comparable to mammography in detecting cancers already present in the breast. However, MDITI™ is the only one that can screen for developing future breast cancer, and do it at more than 90% accuracy!
Approved by the US-FDA and the Philippine Department of Health , MDITI™ is also recognized as a viable diagnostic tool by the:
Every woman who wants to have a better chance of preventing breast cancer, however, it is especially appropriate for women 20-50 years old whose denser breast tissues make it more difficult for mammography to be effective.
Is it painful? How safe is it?
Unlike current breast cancer detecting systems, MDITI™ by HealthQuest® is really safe and PAIN-FREE since it does NOT use RADIATION, CHEMICAL or NEEDLES. There is totally NO contact, NO squeezing, NO pressure and is NON-invasive. It is also safe for pregnant women.
How accurate and accepted is it?
MDITI™'s 83% accuracy is comparable to mammography in detecting cancers already present in the breast. However, MDITI™ is the only one that can screen for developing future breast cancer, and do it at more than 90% accuracy!
Approved by the US-FDA and the Philippine Department of Health , MDITI™ is also recognized as a viable diagnostic tool by the:
- American Medical Association Council on Scientific Affairs
- American Chiropractic Association Council on Diagnostic Imaging
- Council of Neuro-Surgeons
- American Academy of Physical Medicine and Rehabilitation
- An abnormal MDITI™ result is 10 times more significant as a future risk-indicator for breast cancer than a first order family history.
- A persistent abnormal MDITI™ result carries with it a 22x higher risk of future breast cancer.
- An abnormal MDITI™ result is the single most important marker of high risk for developing future breast cancer.
- MDITI™ has the ability to detect the first signs of forming cancer up to 10 years before any other system can detect it.
- As part of a multimodal approach (clinical examination + mammography + MDITI™) 95% of early stage cancers will be detected.
Every woman who wants to have a better chance of preventing breast cancer, however, it is especially appropriate for women 20-50 years old whose denser breast tissues make it more difficult for mammography to be effective.